Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis

Ranu Baral, Maddie White, Vassilios S Vassiliou
doi: https://doi.org/10.1101/2020.05.03.20089375

Article Information

doi 
https://doi.org/10.1101/2020.05.03.20089375
History 
  • May 8, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Ranu Barala,
  2. Maddie Whiteb and
  3. Vassilios S Vassilioua,b,*
  1. aNorfolk and Norwich University Hospital, Norwich, United Kingdom
  2. bNorwich Medical School, University of East Anglia, Norwich, United Kingdom
  1. ↵*Corresponding author:
    Prof Vassilios S Vassiliou MA, MD, PhD, FRCP, FACC, FESC, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7UQ, UK, Tel: 01603592534, Email: v.vassiliou{at}uea.ac.uk
Back to top
Posted May 08, 2020.
Download PDF
Data/Code
Email
Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis
Ranu Baral, Maddie White, Vassilios S Vassiliou
medRxiv 2020.05.03.20089375; doi: https://doi.org/10.1101/2020.05.03.20089375
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area